Communicable (infectious) diseases - several diseases
Individual Documents
| Title: | | Communicable disease risk assessment and interventions |
| Date of publication: | | December 2008 |
| Description/subject: | | Cyclone Nargis: Myanmar (May 2008):
Contents_
Acknowledgements ...
1. Background and risk factors ...
2. Priority communicable diseases ...
3. Immediate interventions for communicable disease control ...
4. Relevant publications … 5. WHO-recommended case definitions ... |
| Language: | | English |
| Source/publisher: | | World Health Organization |
| Format/size: | | pdf |
| Date of entry/update: | | 27 October 2010 |
|
| Title: | | Responding to AIDS, Tuberculosis, Malaria, and Emerging Infectious Diseases in Burma: Dilemmas of Policy and Practice |
| Date of publication: | | 10 October 2006 |
| Description/subject: | | In 2004 the Global Fund to Fight AIDS, Tuberculosis, and Malaria (“Global Fund”) awarded program grants to Burma (Myanmar) totaling US$98.4 million over five years—recognizing the severity of Burma’s HIV/AIDS and tuberculosis (TB) epidemics, and noting that malaria was the leading cause of morbidity and mortality, and the leading killer of children under five years old [1]. For those individuals working in health in Burma, these grants were welcome, indeed [2]. |
| Language: | | English |
| Source/publisher: | | PLoS Medicine |
| Format/size: | | html,pdf (293.64 KB) |
| Alternate URLs: | | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592343/
http://www.plosmedicine.org/article/fetchObjectAttachment.action;jsessionid=BBE6B472713F9A20EA12750... |
| Date of entry/update: | | 28 October 2010 |
|
| Title: | | Responding to AIDS, TB, Malaria and Emerging Infectious Diseases in Burma: Dilemmas of Policy and Practice |
| Date of publication: | | March 2006 |
| Description/subject: | | "...This report seeks to synthesize what is known about HIV/AIDS, Malaria, TB and other
disease threats including Avian influenza (H5N1 virus) in Burma; assess the regional health and
security concerns associated with these epidemics; and to suggest policy options for responding
to these threats in the context of tightening restrictions imposed by the junta..." ...I. Introduction [p. 9-13]
II. SPDC Health Expenditures and Policies [p.14-18]
III. Public Health Status [p.19-42]
a. HIV/AIDS
b. TB
c. Malaria
d. Other health threats: Avian Flu, Filaria, Cholera
IV. SPDC Policies Towards the Three "Priority Diseases" [p. 43-45]
and Humanitarian Assistance
V. Health Threats and Regional Security Issues [p. 46-51]
a. HIV
b. TB
c. Malaria
VI. Policy and Program Options [p. 52-56]
VII. References [p. 57-68]
Appendix A: Official translation of guidelines
Appendix B: Statement by Bureau of Public Affairs
Appendix C: Ministry of Livestock and Fisheries Avian Flu notification. |
| Author/creator: | | Chris Beyrer, MD, MPH; Luke Mullany, PhD; Adam Richards, MD, MPH; Aaron Samuals, MHS; Voravit Suwanvanichkij, MD, MPH; om Lee, MD, MHS; Nicole Franck, MHS |
| Language: | | English, Burmese, Chinese |
| Source/publisher: | | Center for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health |
| Format/size: | | pdf (1.6MB) |
| Alternate URLs: | | http://www.burmalibrary.org/docs6/respondingburmese-ES-bu.pdf (Executive Summary, Burmese, 83K)
http://www.burmalibrary.org/docs6/respondingburmese-ES-ch.pdf (Executive Summary, Chinese, 144K) |
| Date of entry/update: | | 20 April 2006 |
|
| Title: | | Response of falciparum malaria to different antimalarials in Myanmar |
| Date of publication: | | 1999 |
| Description/subject: | | The purpose of the study was to ascertain the therapeutic efficacy of different treatments for uncomplicated falciparum
malaria in the hospitals in Sagaing, northern and eastern Shan, to facilitate updating the existing national antimalarial
drug policy. The proposed 14-day trial for monitoring the efficacy of treatments of uncomplicated falciparum malaria is
an efficient method for identifying treatment failure patterns at the intermediate level (township hospital) in the Union
of Myanmar. Minimal clinical and parasitological data for days 0±14 were required to classify treatment failure and
success. Clinical and parasitological responses on day 3 and days 4±14 were used as clear examples of early and late
treatment failure, respectively. Mefloquine is five times more likely to be effective than chloroquine and sulfadoxine-
pyrimethamine (S-P), whereas chloroquine and S-P treatments have nearly identical failure patterns. The alarming
frequency of clinical and parasitological failure (failure rate >50%) following chloroquine treatment was reported in
Sagaing and following S-P treatment in Sagaing and eastern Shan. |
| Language: | | English |
| Source/publisher: | | World Health Organization |
| Format/size: | | html, pdf |
| Alternate URLs: | | http://74.125.155.132/scholar?q=cache:EesOglB2a_cJ:scholar.google.com/+myanmar+health&hl=en&... |
| Date of entry/update: | | 28 October 2010 |
|
| Title: | | Burma Major infectious diseases |
| Description/subject: | | Major infectious diseases: degree of risk: very high ...
food or waterborne diseases: bacterial and protozoal diarrhea, hepatitis A, and typhoid fever ...
vectorborne diseases: dengue fever and malaria ...
water contact disease: leptospirosis ...
animal contact disease: rabies ...
note: highly pathogenic H5N1 avian influenza has been identified in this country; it poses a negligible risk with extremely rare cases possible among US citizens who have close contact with birds (2009) ...
Definition: This entry lists major infectious diseases likely to be encountered in countries where the risk of such diseases is assessed to be very high as compared to the United States. These infectious diseases represent risks to US government personnel traveling to the specified country for a period of less than three years. The degree of risk is assessed by considering the foreign nature of these infectious diseases, their severity, and the probability of being affected by the diseases present. The diseases listed do not necessarily represent the total disease burden experienced by the local population. |
| Source/publisher: | | Index Mundi |
| Format/size: | | html |
| Date of entry/update: | | 29 October 2010 |
|
|
The World-Wide Web Virtual Library
